Federal Circuit / U.S. Court of Spec. Jurisdiction

Federal Circuit / U.S. Court of Spec. Jurisdiction
(incl: International Trade (Customs), Federal Claims, Armed Forces, Federal Adm. Agencies & Boards, Immigration, Tax, Gov. Personnel Appeals, Patent , Trademark, Veterans Appeals, etc.)

Custom text Title Organization
Apr
18
2017
 Angiomax Patents Limited To Example Foley & Lardner LLP
Sep
3
2015
 Another Claim Bites the Dust left by Teva v. Sandoz Schwegman, Lundberg & Woessner, P.A.
Apr
11
2016
 Another Diagnostic Patent Falls Under 101 Foley & Lardner LLP
Nov
29
2018
 Another Diagnostic Test Found Ineligible Under § 101 McDermott Will & Emery
Jan
28
2018
 Another Domestic Industry Lesson For Section 337 Litigants Squire Patton Boggs (US) LLP
Aug
6
2011
 Another Federal Court of Appeals Weighs in on the Applicability of the Six-Year Statute of Limitations Period to an Overstatement of Basis McDermott Will & Emery
Apr
9
2018
 Another Federal Decision Broadens Trademark Protection Davis|Kuelthau, s.c.
Oct
18
2016
 Another Friendly Reminder from the CAFC – Use of “the Present Invention” is Clear and Unequivocal Evidence of Disavowal Mintz
Jul
19
2021
 Another Gaming Patent Struck Down as Ineligible Bradley Arant Boult Cummings LLP
Sep
9
2021
 Another Genus Claim Bites the Dust for Lack of Written Description McDermott Will & Emery
Nov
17
2022
 Another Kind of Term Limit: Delay Resulting from After-Allowance Amendments Deducted from PTA McDermott Will & Emery
Dec
30
2016
 Another Look at Willful Infringement under Halo’s Preponderance of the Evidence Standard McDermott Will & Emery
Sep
2
2015
 Another Noel Canning Rubber Stamp- Obama NLRB Overturns 1962 Case and Holds that Dues Checkoff Duty Now Continues Beyond Contract Expiration Barnes & Thornburg LLP
Oct
6
2014
 Another One Bites the Dust: NLRB Now Rules Certain "No-Disruption Rules" Are Unlawful Barnes & Thornburg LLP
Jun
2
2015
 Another Sequenom Patent Appeal Heads To The Federal Circuit Foley & Lardner LLP
Jun
29
2016
 Another Unregistrable Trademark Surname: DICKMAN’S Pickles Mintz
Dec
3
2012
 Another Voting Machine Controversy in Florida? (This Time It’s about Patent Infringement) McDermott Will & Emery
Nov
20
2014
 Antares Pharma Bolsters the “Original Patent” Rule for Reissued Patents Michael Best & Friedrich LLP
Mar
30
2015
 Antedating by Third-Party Reduction to Practice Not Enough: Sensio Inc v. Select Brands McDermott Will & Emery
Dec
21
2023
 Anticipation and Obviousness in Patent Law: An Analysis of Recent IPR Decisions Sheppard, Mullin, Richter & Hampton LLP
May
3
2015
 Anticipation Found Even Where the Prior Art Did Not Disclose Limitations Arranged the Same Way as in the Claim McDermott Will & Emery
Feb
2
2017
 Antidote for Acetaminophen Overdoses Not Invalid as Either Derived From Another or Obvious Over the Prior Art Hunton Andrews Kurth
Mar
5
2020
 Antitrust Liability Risk When Listing Patents in Orange Book McDermott Will & Emery
Mar
30
2015
 AOL Inc. and Cloudera, Inc. v. Coho Licensing LLC: Denying Petitioner’s Request for Expanded Panel IPR2014-00771 Faegre Drinker
Dec
4
2014
 AOL, Inc. and Cloudera, Inc. v. Coho Licensing LLC: Decision Denying Institution IPR2014-00771 Faegre Drinker
Apr
9
2015
 Apotex Has Standing Despite Benicar Patent Disclaimer Foley & Lardner LLP
Sep
15
2015
 Apotex Inc. v. Merck Sharp & Dohme Corp: Decision Denying Institution IPR2015-00419 Faegre Drinker
Sep
20
2015
 Apotex Inc. v. Wyeth LLC, Denying Institution Where Petitioner had not Established a Reasonable Likelihood of Prevailing on at Least One Claim IPR2015-00873 Faegre Drinker
Jul
23
2014
 Apotex Inc. v. Wyeth LLC, Denying Motion for Leave to File Motion for Additional Discovery IPR2014-00115 Faegre Drinker
Jul
8
2014
 Apotex Inc. v. Wyeth LLC, Granting Motion for Leave to File Supplemental Evidence IPR2014-00115 Faegre Drinker
May
21
2015
 Apotex Petitions Supreme Court to Review Therasense Standards Schwegman, Lundberg & Woessner, P.A.
Sep
1
2016
 Apotex v Wyeth Explores Structural Obviousness Schwegman, Lundberg & Woessner, P.A.
Jul
6
2016
 Apotex—Biosimilars Must Provide 180-Day Marketing Notice After FDA Approval Morgan, Lewis & Bockius LLP
Oct
26
2017
 Appeal of Discovery Order in BPCIA Patent Infringement Case Dismissed for Lack of Jurisdiction and Writ of Mandamus for Compelling Discovery Denied Hunton Andrews Kurth
Jun
14
2018
 Appeals Court Rejects Insurers Risk Corridors Claims Mintz
Subscribe to Federal Circuit / U.S. Court of Spec. Jurisdiction
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins